Przejdź do treści
Our offer
Consulting
We provide strategic consulting for biomedical companies, scientists, and investors. Our multidisciplinary team, including experienced grant reviewers, uniquely combines scientific insight, regulatory expertise, and business acumen rarely found in one place. We help our clients navigate key business and technology decisions and increase their chances of success in highly competitive funding programs such as Horizon Europe.
We help ventures launch, scale, and commercialize innovation effectively. Our approach uniquely bridges science and business, enabling each project to reach its full development potential – something few firms can deliver end-to-end.
We empower small and growing companies to achieve dynamic, sustainable growth. Our team advises clients on securing grants and development funding, assesses the commercial potential of projects, and supports the preparation of competitive proposals – making their scientific and market value clear to reviewers.
Bioethical oversight
Our team is composed of respected specialists who have served for years as ethics advisors and auditors in research, R&D projects, and international grant programmes. As Independent Ethics Advisors, we provide comprehensive bioethical oversight – delivered flexibly or tailored to individual projects – a service that distinctively combines scientific insight, regulatory understanding, and ethical integrity.
We ensure that every project meets the highest ethical standards.
As independent advisors and coordinators, we provide ethics reports, conduct audits, and offer regulatory guidance upon request.
Our involvement guarantees continuous ethical oversight and ongoing support for organizations, ensuring that projects are managed responsibly, transparently, and in line with international norms.
This allows our clients to focus on innovation — confident that every stage of their work complies with ethical and legal requirements.
We do not advise on projects involving experiments on human embryos or fetuses that could cause their harm or destruction.
Likewise, we do not support studies in which the suffering of animals or patients is not justified by a significant scientific or therapeutic purpose. Our values are grounded in the highest ethical standards, respect for life, and scientific responsibility.
As part of our comprehensive bioethical oversight, we offer:
(e.g., Horizon Europe).
We offer flexible solutions — from subscription-based bioethical support to individual advisory services — tailored to each client’s specific needs.
Due Diligence
We conduct advanced and detailed Technical Due Diligence, providing investors, venture capital funds, banks, and business angels with in-depth, unbiased evaluations of biomedical projects. Our approach stands out by combining recognized scientific authority with financial acumen — assessing technological and financial potential, team capabilities, commercialization feasibility, and long-term impact within a single comprehensive review.
We deliver in-depth analyses of markets, competition, and entry strategies, using our sector expertise to help clients identify ventures with high growth and profit potential — and avoid underperforming investments.
Our methodology turns data into actionable insights, equipping investors with strategic tools to minimize risk and identify breakthrough innovations ready for global expansion. With our expertise, investors make confident, informed, and secure decisions. We protect their capital and help maximize returns.
You don’t have to know everything as an investor — our top experts safeguard your interests at every step.
Reports & Analytics
Business analytics and reporting — including rapid HTA reports — are key tools supporting decision-making in healthcare and biobusiness.
We employ advanced data analysis methods rarely matched by competitors to identify trends, optimize processes, and guide strategic choices. Our rapid HTA reports provide comprehensive evaluations of the effectiveness, safety, and cost-effectiveness of medical technologies, supporting reimbursement, clinical, and strategic processes. Through reliable, data-driven analyses, we help institutions and companies make evidence-based decisions, minimize risk, and maximize operational efficiency. We also support business angels, venture capital funds, and investors by assessing the commercial and technological potential of innovations and verifying the real capabilities of the companies behind them. Reports are prepared in English, or upon request, in Polish, Spanish, German, and French.
Risk Assessment
In today’s dynamic biomedical landscape, every innovation faces multiple challenges. Our risk assessment expertise helps companies and investors make informed, confident decisions. We identify and eliminate potential threats, implement corrective actions swiftly, and unlock the full potential of emerging technologies. We assess and analyze key risks at both research and market stages – minimizing uncertainty and maximizing the chances of success.
When evaluating technological risks, we examine whether a project is feasible, realistic, and scalable.
We assess the likelihood of non-completion by analyzing factors such as technical constraints, unforeseen research challenges, and limited access to critical resources.
We also evaluate intellectual property risks, including potential patent infringements or conflicts with existing technologies, and ensure that each solution’s novelty is fully protected. Our experts verify that IPR protection strategies align with long-term commercialization goals and support sustainable market entry.
In assessing market risk, we identify barriers to entry and competitive dynamics. We evaluate the acceptance of new solutions as well as potential regulatory and reimbursement challenges. Our team helps companies tailor their market strategies to minimize exposure and increase the likelihood of success. We also analyze logistical and operational risks — from supply chain disruptions and component shortages to compliance with quality and regulatory standards across different jurisdictions.
Through our comprehensive and interdisciplinary approach, we deliver actionable recommendations that protect capital, reduce uncertainty, and optimize implementation strategies. Partnering with us means gaining analysis backed by deep industry expertise and a clear strategic perspective.
Audits
Our audits guarantee quality, safety, and market success.
They help companies and institutions identify gaps, eliminate risks, and optimize processes – ensuring compliance with current standards and improving their chances of success. We conduct technological audits
that assess the innovativeness, maturity, and feasibility of biomedical technologies. We verify the conformity of solutions with the current state of knowledge and analyze their effectiveness, scalability, and implementation readiness. This allows companies to manage their R&D projects more effectively and strategically. Our audits also evaluate
financial models, commercialization strategies, and market potential
– analyzing investment profitability, competitive advantages, and market entry barriers. We help companies minimize risk and enhance both market and investment performance.
Within regulatory audits, we verify project compliance with local and international legal requirements as well as industry standards. We assess documentation, R&D procedures, and ethical frameworks – accelerating certification and market approval processes.
We also audit projects co-funded by the EU or implemented within grant programs. We verify compliance with formal requirements, funding regulations, and project objectives – helping companies execute their projects smoothly and utilize funds efficiently.
Our audits ensure that companies meet formal standards and continuously improve internal processes. This enhances operational efficiency and builds a sustainable competitive advantage. With our expertise, your project remains secure, fully compliant, and ready for market success.
Project & Business Partner Verification
Our approach to verifying biomedical projects is meticulous — almost detective-level. Unlike standard background checks, we assess the scientific, technological, and commercial potential of ventures, as well as the credibility of business partners. We use advanced verification methods, including documentation audits, company history analysis, and on-site inspections – regardless of global location. This depth of verification truly sets our service apart. Through detailed analysis, we identify risks such as overestimated organizational capacity or inflated market potential. We eliminate ventures that fail to meet the standards of feasibility and profitability. We go far beyond surface-level assessments – examining every aspect of operations and collaboration to minimize the risk of fraud, misrepresentation, or unethical practices. We support investors and companies in building safe, reliable partnerships and avoiding costly mistakes. Our approach drives genuine project growth – ensuring strong market potential and long-term success.
Support for Companies & Researchers
We support small, medium-sized and big enterprises as well as researchers from various fields – helping them grow and succeed at every stage of their development. Our services cover the entire innovation journey: from early project planning through product commercialization. We provide strategic support that includes growth and development planning, financing acquisition, process optimization, market entry, and comprehensive assistance in communication and promotion. Our actions help companies and researchers build visibility, reach the right audiences, and create a strong, positive image – all crucial for securing funding and attracting customers. We also assist scientists in commercializing their discoveries, turning breakthrough ideas into real products and effectively monetizing their knowledge. We help companies and institutions thrive – because our clients’ success and satisfaction are our top priorities.
Professional Training for Companies, Biotech Innovators & the Biobusiness Sector
We train current and future leaders in the biomedical industry.
Our programs educate doctors, medical professionals, and company employees — including those from pharmaceutical firms – in biomedicine, biomedical technologies, and bioethics. We also organize workshops and lectures designed to popularize science and promote knowledge. As recognized experts in the field, we host events featuring Key Opinion Leaders, fostering innovative thinking and raising awareness within the scientific and business communities.
In addition, we support researchers by teaching them how to effectively monetize their knowledge and translate discoveries into practical market solutions. Our training programs prepare participants to make sound business decisions and develop innovative projects by equipping them with the skills needed to succeed in the fast-moving biomedical sector.
Our specialized trainings and workshops — covering biobusiness, analytics, regulation, and commercialization strategy — help companies, investors, and researchers build the competencies required to manage biomedical projects effectively. Each program is tailored to participants’ specific needs, combining solid theoretical foundations with a hands-on, practical approach. Beyond knowledge transfer, we focus on
transforming mindsets and unlocking hidden potential. We help participants grow as professionals, increase confidence, and develop the innovative thinking essential for long-term success. We are building competence and confidence in the life sciences industry.